Tourmaline Bio, Inc. (TRML) Stock: News, Analysis, Q&A, and Insights

Investment Analysis Report: TRML

Overview

TRML is a company operating in the Health Technology sector, specifically in the Biotechnology industry. The company has a market capitalization of $1.09 billion. In this report, we will conduct a comprehensive analysis of TRML's financial statements over the past three years, focusing on the Balance She...

Technical Analysis of TRML 2024-05-10

Overview:

In analyzing the technical indicators for TRML over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day Moving Average (MA) has been declining, indicating a ...

Recent News & Updates

2024-05-15 19:00
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial(Globenewswire)
2024-05-13 01:54
TRML Stock Earnings: Tourmaline Bio Beats EPS for Q1 2024(Investorplace)
2024-05-12 19:00
Tourmaline Bio Reports First Quarter 2024 Financial Results and Recent Business Highlights(Globenewswire)
2024-04-02 07:00
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors(GlobeNewswire)
2024-04-01 19:00
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors(Globenewswire)
2024-03-19 07:00
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights(GlobeNewswire)
2024-03-19 02:52
TRML Stock Earnings: Tourmaline Bio Reported Results for Q4 2023(Investorplace)
2024-03-18 19:00
Tourmaline Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights(Globenewswire)
2024-03-14 20:50
Here's Why Momentum in Tourmaline Bio, Inc. (TRML) Should Keep going(Zacks)
2024-03-01 06:05
Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock(Simply Wall St.)
2024-02-27 19:50
Here's What Could Help Tourmaline Bio, Inc. (TRML) Maintain Its Recent Price Strength(Zacks)
2024-02-27 07:30
Tourmaline Bio to Present at Upcoming Investor Conferences(GlobeNewswire)
2024-02-26 18:30
Tourmaline Bio to Present at Upcoming Investor Conferences(Globenewswire)
2024-02-07 19:50
What Makes Tourmaline Bio, Inc. (TRML) a Good Fit for 'Trend Investing'(Zacks)
2024-02-01 08:00
Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference(GlobeNewswire)
2024-01-31 19:00
Tourmaline Bio to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference(Globenewswire)
2024-01-29 16:01
Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares(GlobeNewswire)
2024-01-29 03:01
Tourmaline Bio Announces Closing of $172.5 Million Public Offering of Common Stock, Including Full Exercise of the Underwriters' Option to Purchase Additional Shares(Globenewswire)
2024-01-25 07:00
Tourmaline Bio Announces Pricing of Public Offering of Common Stock(GlobeNewswire)
2024-01-24 18:00
Tourmaline Bio Announces Pricing of Public Offering of Common Stock(Globenewswire)
2024-01-24 16:05
Tourmaline Bio Announces Proposed Public Offering of Common Stock(GlobeNewswire)
2024-01-24 03:05
Tourmaline Bio Announces Proposed Public Offering of Common Stock(Globenewswire)
2024-01-08 07:00
Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)(GlobeNewswire)
2024-01-07 18:00
Tourmaline Bio Announces Expected Upcoming Key Milestones for the Clinical Development of TOUR006, a Long-Acting Subcutaneous Inhibitor of IL-6 with Best-in-Class Potential, in Thyroid Eye Disease (TED) and Atherosclerotic Cardiovascular Disease (ASCVD)(Globenewswire)
2023-12-15 16:00
Tourmaline Bio added to the NASDAQ Biotechnology Index(GlobeNewswire)
2023-12-15 03:00
Tourmaline Bio added to the NASDAQ Biotechnology Index(globenewswire)
2023-12-14 07:30
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board(GlobeNewswire)
2023-12-13 18:30
Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board(globenewswire)
2023-11-01 08:00
Tourmaline Bio to Present at Upcoming Investor Conferences(GlobeNewswire)
2023-10-31 20:00
Tourmaline Bio to Present at Upcoming Investor Conferences(globenewswire)

Page 1 of 3

previousnext

Home

Market Lens

Ideas Explorer

History

Recent Activity

TRML

Performance

Profile